Session 24

 

Monday, September 4
8:00 – 10:00 am

Room 3

 

 

Surgical treatments

 

Chairs: Arnulf H. Hölscher (Germany) – Paul M. Schneider (Switzerland)

Discussants: Zhen-tao Yu (China) – Denis Collet (France)

 

• The evidence-based advantages of minimally invasive surgery for esophageal resection. 
  Suzanne Gisbertz (Netherlands)
• What are the advantages of robot esophagectomy? Sylvia van der Horst (Netherlands)
• Is there today a place for open esophagectomy? Paul M. Schneider (Switzerland)
• What is the best position for thoracoscopic resection: prone position? – left lateral position?
  Mark I. van Berge Henegouwen (Netherlands)
• What is the best location for the esophago-gastric anastomosis? Philippe Nafteux (Belgium)
• Can VATS esophagectomy dissect the the lymph nodes along bi-recurrent laryngeal nerve as effectively as open esophagectomy? Yong-tao Han (China)
• Experience of VATS esophagectomy after preoperative chemoradiation for locally advanced esophageal cancers. Jian-hua Fu (China)
• Results of prospective randomized study of surgical treatment through left chest approach versus through right chest approach. Hai-quan Chen (China)
• What are the key points of modular manipulation of VATS esophagectomy in China? Li-jie Tan (China)
• Is three field lymph node dissection necessary for all thoracic esophageal cancer patients?
  Shuo-yan Liu (China)
• Mobilization and reconstruction stages for transthoracic + laparoscopic esophagectomy for gastroesophageal junction cancer. Sergei Domratchev (Russia)
• Mobilization and reconstruction stages for transhiatal esophagectomy for gastroesophageal junction cancer. Jens Höppner (Germany)
• What are the results of hybrid esophagectomy? Arnulf H. Hölscher (Germany)
• Significance of fast track esophagectomy – What is the real benefit for the patient and the hospital?
  Donald L. van der Peet (Netherlands)